Losartan Potassium Price Trend and Forecast 2026: Latest Global Market Analysis and Industry Outlook

 

According to ChemAnalyst, the Losartan Potassium Price market strengthened across several major regions during the second quarter of 2026, supported by strong Asian export demand, tighter prompt availability, higher freight and insurance expenses, and steady pharmaceutical consumption. In the United States, Losartan Potassium prices hovered around USD 39,735/MT on a CFR basis, while China recorded an average price of approximately USD 38,933.33/MT on an FOB basis during Q2 2026. India also experienced a quarterly price increase, while the European market remained firm amid steady Asian imports and disciplined procurement.

Losartan Potassium Price Trend in Q2 2026

The global Losartan Potassium Price Trend remained firm during Q2 2026 as pharmaceutical manufacturers and distributors maintained regular procurement while export availability from Asian suppliers became comparatively tighter. Losartan Potassium is an active pharmaceutical ingredient (API) used in medicines for hypertension, making its demand closely connected to pharmaceutical formulation activity, institutional procurement, and healthcare programs.

In North America, the Losartan Potassium Price Index moved upward quarter-over-quarter. The market was influenced by strong Asian export allocations, elevated trans-Pacific freight and insurance costs, and tighter inventories at major US distribution locations. Asian producers maintained high operating rates, but longer transit times and war-related shipping rerouting increased landed costs.

China also recorded a significant increase during the quarter. The Losartan Potassium Price index rose by 9.98% quarter-over-quarter, with the average price reaching approximately USD 38,933.33/MT FOB. Strong export enquiries, particularly from the United States and Brazil, absorbed available volumes and encouraged producers to maintain firmer offers.

India recorded a 3.36% quarter-over-quarter increase in the price index. Higher input expenses, tighter environmental discharge requirements, freight inflation, and increased conversion and intermediate costs contributed to the upward movement.

In Europe, Germany experienced a firm upward price trend. Stable Asian FOB offers were combined with higher EU port-handling and compliance-related expenses, keeping landed costs elevated. Steady pharmaceutical formulation activity and institutional procurement provided additional support to the market.

Losartan Potassium Price Analysis by Region

North America

The North American Losartan Potassium Price Trend strengthened during Q2 2026. The United States remained heavily influenced by imported API availability, particularly from Asian suppliers.

Losartan Potassium prices were approximately USD 39,735/MT CFR during the quarter. Tightened inventories in Houston and on the US West Coast supported seller confidence, while strong pharmaceutical demand absorbed available volumes.

Another important factor was international logistics. War-related rerouting increased transit times and insurance costs, raising the landed cost of imported Losartan Potassium. Although Asian producers maintained relatively high operating rates, longer shipping routes reduced the immediate flexibility of US buyers.

The near-term outlook points toward moderate gains followed by a possible correction once US inventories stabilize. Pharmaceutical consumption is expected to remain steady, limiting the potential for a sharp decline in prices.

China

China remained a key market for the global Losartan Potassium Price due to its significant API production and export role.

During Q2 2026, the Chinese price index increased 9.98% quarter-over-quarter, with an average price of approximately USD 38,933.33/MT FOB Zhejiang. Exporters allocated more prompt material toward overseas markets, particularly the United States and Brazil, supporting firmer prices.

Although inventories accumulated at some warehouses, producers directed material into export parcels, helping maintain offer discipline. Domestic procurement was more constrained because of price-ceiling policies, meaning that export demand played a particularly important role in supporting the market.

Production facilities along China's coastal API manufacturing regions continued operating at relatively high rates. Environmental upgrades helped producers maintain compliance without major supply disruptions.

India

The Indian Losartan Potassium Price Trend also moved higher during Q2 2026. ChemAnalyst recorded a 3.36% quarter-over-quarter increase in India's price index.

Higher input and compliance costs were key contributors. Tighter discharge requirements increased conversion and intermediate expenses, while freight inflation added to the delivered cost of material.

India's pharmaceutical manufacturing sector remains an important source of Losartan Potassium demand. Continued formulation activity and API procurement should provide a stable underlying demand base, although buyers may remain sensitive to price changes when import and domestic alternatives are available.

Europe

Germany's Losartan Potassium market remained firm during Q2 2026. Strong Asian export demand tightened prompt availability, while EU port-handling charges and compliance-related costs increased the landed cost of imported material.

European distributors continued to follow disciplined purchasing strategies, avoiding excessive speculative inventory accumulation. Nevertheless, consistent pharmaceutical formulation activity and institutional procurement provided reliable demand.

The European Losartan Potassium Price Trend is therefore expected to remain relatively stable to firm in the near term, although normalization of inventories could create some downward pressure.

𝐓𝐫𝐚𝐜𝐤 𝐑𝐞𝐚𝐥-𝐓𝐢𝐦𝐞 𝐏𝐫𝐢𝐜𝐞𝐬 𝐎𝐟 𝐋𝐨𝐬𝐚𝐫𝐭𝐚𝐧 𝐏𝐨𝐭𝐚𝐬𝐬𝐢𝐮𝐦 𝐏𝐫𝐢𝐜𝐞

https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Losartan%20Potassium

Losartan Potassium Price Movement in Q1 2026

The first quarter of 2026 presented a more mixed market environment.

In China, the Losartan Potassium Price index declined 2.70% quarter-over-quarter, with the average quarterly price at approximately USD 35,400/MT. The decline was initially associated with weaker export demand and elevated inventories. However, the market strengthened during March as export enquiries increased and bonded inventories tightened.

GMP re-qualification temporarily reduced export-qualified capacity, tightening supply and supporting firmer FOB offers. US and Brazilian tender activity also accelerated purchases and reduced available bonded stocks.

In North America, the price index declined slightly during Q1, reflecting sufficient inventory coverage and weaker import demand earlier in the quarter. By March, however, tightening Chinese export availability and increased tender-driven procurement improved market conditions.

Europe followed a similar pattern. Early-quarter demand was relatively subdued, but prices strengthened during March as reduced Asian export availability and improved pharmaceutical procurement tightened prompt supply.

Historical Losartan Potassium Price Trend

The Losartan Potassium Price Trend showed greater weakness during Q3 2025. In China, the price index declined 2.66% quarter-over-quarter, while the average quarterly price was approximately USD 50,100/MT FOB Zhejiang.

High inventories, weak export orders, and cautious downstream procurement limited price recovery. Producers also resumed operations following maintenance, increasing market availability. Lower feedstock expenses further contributed to pricing pressure.

The market subsequently stabilized. During Q4 2025, China's price index increased 0.53% quarter-over-quarter, with an average price of approximately USD 36,383.33/MT FOB Zhejiang. Balanced export bookings supported spot prices, while domestic procurement remained cautious.

This historical movement demonstrates the importance of inventory cycles and export demand in determining Losartan Potassium prices. Periods of high availability can place considerable pressure on producers, while stronger overseas procurement can quickly tighten export availability.

Key Factors Affecting Losartan Potassium Price

Several factors influence the global Losartan Potassium Price Trend:

1. Pharmaceutical Demand

Losartan Potassium is widely used as an API in antihypertensive medicines. Consistent pharmaceutical formulation activity provides a stable baseline for demand.

2. Export Demand

International procurement, particularly from major pharmaceutical markets such as the United States and Brazil, has become an important price driver. Higher export enquiries can reduce domestic availability in producing countries and support higher offers.

3. GMP Compliance

Good Manufacturing Practice requirements can influence available production capacity. Requalification or compliance-related changes can temporarily reduce export-qualified supply and affect international pricing.

4. Raw Material Costs

The production economics of Losartan Potassium are influenced by intermediate and potassium-based feedstock costs. ChemAnalyst notes that imidazole- and tetrazole-based intermediate costs can place upward pressure on production expenses.

5. Environmental Compliance

Stricter environmental and discharge regulations can increase manufacturing costs. Higher compliance expenses were among the factors supporting the Q2 2026 production-cost trend in China and India.

6. Freight and Insurance

International transportation plays an important role in landed API prices. Longer shipping routes, rerouting, port costs, and higher insurance premiums can increase the final price paid by pharmaceutical buyers.

7. Inventory Levels

Inventory availability can quickly change market sentiment. Higher inventories reduce procurement urgency and encourage buyers to negotiate, while declining stocks can support stronger seller offers.

Losartan Potassium Production and Applications

Losartan Potassium is the potassium salt of Losartan and is an active pharmaceutical ingredient with the molecular formula C22H22ClKN6O. It is supplied as a white to off-white, practically odorless powder.

The compound belongs to the angiotensin II receptor antagonist class. It is used in pharmaceutical formulations designed to treat hypertension. Losartan API competitively interacts with the angiotensin II type 1 (AT1) receptor, preventing angiotensin II from binding and supporting vasodilation.

Losartan Potassium can be incorporated into different pharmaceutical dosage forms, including:

• Tablets

• Capsules

• Suspensions

• Other oral pharmaceutical formulations

According to ChemAnalyst, the product is available in API Grade and USP Grade, with purity above 99.5%. The listed CAS number is 124750-99-8, while the HS code is 29332990. The contract size is approximately 25 kg, with fibre HDPE drums used for packaging.

Losartan Potassium Price Forecast 2026

The Losartan Potassium Price Forecast for the remainder of 2026 will largely depend on export demand, inventory availability, pharmaceutical procurement cycles, raw material expenses, and international logistics.

Recent developments in China suggest that the market may experience a period of stabilization after the Q2 price increase. ChemAnalyst reported that Chinese Losartan Potassium prices increased 1.28% month-over-month in July 2026, supported by tighter prompt availability and stronger export demand. In the first half of August, prices stabilized as inventories improved and buyers became more cautious.

For the second half of August and September, ChemAnalyst expects moderate downward pressure as inventories become more comfortable. However, elevated costs for imidazole- and tetrazole-based intermediates and continued export demand are expected to limit the downside.

Looking further ahead, market conditions could become firmer toward late Q4. Pre-year-end restocking, holiday-related logistics constraints, and sustained raw-material costs may tighten availability from October onward. Any increase in US or Brazilian procurement, changes in producer allocation, or unexpected logistics disruptions could also accelerate price recovery.

North America is expected to remain closely tied to Asian export availability and freight costs. Europe should continue to experience stable pharmaceutical demand, although inventory normalization may create temporary price corrections.

Conclusion

The global Losartan Potassium Price Trend during 2026 has been shaped by a combination of pharmaceutical demand, Asian export allocations, inventory levels, production costs, GMP compliance, and international logistics.

Q2 2026 was characterized by stronger pricing across major markets. China recorded a 9.98% quarter-over-quarter increase, while India increased by 3.36%. In the United States, prices reached approximately USD 39,735/MT CFR, while China's average price was approximately USD 38,933.33/MT FOB.

The market subsequently moved toward a more balanced position in China as inventories improved during August. Nevertheless, elevated intermediate costs and continued export demand are expected to provide a floor under prices.

For pharmaceutical manufacturers, distributors, procurement teams, and traders, monitoring API inventories, export enquiries, GMP-related production availability, raw material costs, freight rates, and healthcare procurement cycles will remain important for understanding future Losartan Potassium Price movements.

Frequently Asked Questions

What was the Losartan Potassium Price in China in June 2026?
According to ChemAnalyst, Losartan Potassium prices in China stood at approximately USD 39,000/MT in June 2026.

What was the Losartan Potassium Price in India in June 2026?
The June 2026 Losartan Potassium price in India was approximately USD 37,229.87/MT, according to ChemAnalyst.

What drove the Losartan Potassium Price increase in Q2 2026?
Strong Asian export demand, tighter prompt availability, higher freight and insurance expenses, environmental compliance costs, and steady pharmaceutical demand contributed to the firmer Q2 market.

What is the Losartan Potassium Price Trend for the rest of 2026?
The market may remain balanced to slightly softer in the short term as inventories improve, while elevated intermediate costs and export demand could provide support. ChemAnalyst expects conditions to potentially become firmer toward late Q4 as restocking and logistics constraints develop.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Email: sales@chemanalyst.com

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_